Research advances in myocardial injury caused by COVID-19
Author(s) -
Jianjun Chen,
Yingfeng He,
Liangliang Zhou,
Genhua Mu,
JI You-lin
Publication year - 2020
Publication title -
cardiovascular diagnosis and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.83
H-Index - 22
eISSN - 2223-3660
pISSN - 2223-3652
DOI - 10.21037/cdt-20-349
Subject(s) - medicine , covid-19 , incubation period , coronavirus , respiratory system , transmission (telecommunications) , intensive care medicine , disease , virology , incubation , infectious disease (medical specialty) , outbreak , biochemistry , chemistry , electrical engineering , engineering
Coronavirus disease 2019 (COVID-19) caused a large-scale infection in China at the end of 2019. The virus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has the characteristics of strong transmission capacity, diverse clinical manifestations, long incubation period, strong infection in incubation period, etc. With the increase of the number of cases and the continuous improvement of clinical data, we found that patients with COVID-19 have myocardial injury besides typical respiratory system manifestations. According to published data, we summarized the clinical manifestations of myocardial injury in COVID-19 patients, and discussed the probable injury mechanism, treatment methods and future research directions.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom